florin lazăr phd, lecturer doru buzducea phd, assoc . prof

17
Facultatea de Sociologie și Asistență Socială Universitatea din București The challenges of care and support for a generation of nosocomially infected young adults from Romania living with HIV Florin Lazăr PhD, Lecturer Doru Buzducea PhD, Assoc. prof. University of Bucharest, Faculty of Sociology and Social Work

Upload: aldona

Post on 20-Feb-2016

43 views

Category:

Documents


0 download

DESCRIPTION

The challenges of care and support for a generation of nosocomially infected young adults from Romania living with HIV . Florin Lazăr PhD, Lecturer Doru Buzducea PhD, Assoc . prof . University of Bucharest, Faculty of Sociology and Social Work . Introduction (1). - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Florin  Lazăr PhD, Lecturer Doru Buzducea  PhD, Assoc . prof

Facultatea de Sociologieși Asistență Socială

Universitatea din București

The challenges of care and support for a generation of nosocomially infected

young adults from Romania living with HIV

Florin Lazăr PhD, LecturerDoru Buzducea PhD, Assoc. prof.

University of Bucharest, Faculty of Sociology and Social Work

Page 2: Florin  Lazăr PhD, Lecturer Doru Buzducea  PhD, Assoc . prof

10,000 children nosocomially (use of unsafe syringes and blood products) infected (1988-1992, 50% of AIDS pediatric in Europe until 2000) - about 3,000 died and other 7,000 have survived for over 22 years with HIV.

1996-1998 ART Average survival ratio of people with AIDS

increased from 31 months in 1996 to 82 months in 2010

Introduction (1)

Page 3: Florin  Lazăr PhD, Lecturer Doru Buzducea  PhD, Assoc . prof

overprotection from the family stigma, and

discrimination in education

health care focusDeveloping social services

Page 4: Florin  Lazăr PhD, Lecturer Doru Buzducea  PhD, Assoc . prof

a peak increase of those availing of social entitlements (see table), 2004-2010 Global Fund projects implemented a higher proportion receiving cash benefits (a food allowance) which

ensures greater confidentiality.

*requires social inquiry/registration with local authorities**paid to bank account, based on medical certificate

Introduction (2)

2005 2012-Q1

# PLWHA registered with medical services 11,187 10,903% PLWHA registered as people with disabilities*

38.6% 53.5%

% PLWHA receiving food allowance** 45.2% 65.9%

Page 5: Florin  Lazăr PhD, Lecturer Doru Buzducea  PhD, Assoc . prof

Romania is now a low prevalence country for HIV (0.1%)

ARV coverage – 81-83%

BUT In 2010 – unintended treatment interruptions Budgetary cuts & delays in ARV procurement NGOs protests

Introduction (3)

Page 6: Florin  Lazăr PhD, Lecturer Doru Buzducea  PhD, Assoc . prof

Objectives

To assess the access to ARV therapy for PLHIV in Romania

To describe the scope of treatment interruptions in 2010

Page 7: Florin  Lazăr PhD, Lecturer Doru Buzducea  PhD, Assoc . prof

A nationally representative clinic-based research among PLHIV (15+ years, N=618, ±4% )

March –June 2011 Sample was weighted according to subjects' surveillance center

registration (9 centers) Data collection – by professionals from CBOs & organisations of PLHIV

(UNOPA, Sens Pozitiv, ARAS & Alături de Voi) Ethics Committee of Faculty of Sociology and Social Work, University of

Bucharest approval

Measures demographics, treatment interruptions, VL&CD4, adherence, access to

services.

Methods

Page 8: Florin  Lazăr PhD, Lecturer Doru Buzducea  PhD, Assoc . prof

Age groups % Marital status %

15-17 years 0.7% Married/remarried/consensual 31.1%18-24 years 71.7% Celibacy/Divorced/separated 66.4%25+-29 years 5.0% Housing 30+ years 22.6% Owner/family 74.0%

Gender   Rented 15.9%Females/Males 49.4%/50.6% Social housing (protected

shelter/family type/residential)7.4%

Most recent education No housing 0.7%

No education 3.8% Way of infection

Secondary or less 32.2%Infected medical equipment/ hospital 64.2%

Vocational school 16.1% Infected blood transfusion 7.6%

High school 37.0% Mother-to-child 0.9%

University 10.1% Unprotected sexual intercourse 10.2 %

Main source of incomes Injection of drugs 1.1% Social allowances (indemnities, food allowances, pension) 86.0% Other 3%

Wage/business 9.7% DK/NA 13.1%

Other (family, partner) 3.7%

Sample characteristics

Page 9: Florin  Lazăr PhD, Lecturer Doru Buzducea  PhD, Assoc . prof

Duration with HIV6 + years 82.1%

Average duration10

yearsDuration with ARV6+ years 78.4%CD 4 count (self-declared)

0-350 23.0

%

>35053.3

%

DK23.7

%Viral load (self-declared)

undetectable21.2

%detectable 11.1%

DK67.7

%

Medical conditionLast CD4

Last VL

Page 10: Florin  Lazăr PhD, Lecturer Doru Buzducea  PhD, Assoc . prof

Alternative treatment

Reason for last change

TreatmentFrequency of visits to regional center

in 2010 for ART

Number of schemes changed

Page 11: Florin  Lazăr PhD, Lecturer Doru Buzducea  PhD, Assoc . prof

Unintended treatment interruptions in 2010

• No differences by age, occupation, education, income, gender or ethnicity

• Average interruption: 38 days

How many times was your medication scheme replaced due to the absence of the original medication in 2010? N Percentage

At least once 101 16.3%

DK/NA 517 83.7%

Page 12: Florin  Lazăr PhD, Lecturer Doru Buzducea  PhD, Assoc . prof

What did you do when you didn’t receive the ARV therapy in 2010 from your hospital N Percent

I received it from another hospital 75 19.90% I bought it at a pharmacy 12 3.20%

I borrowed from a friend 70 18.70%

I didn’t take any treatment 297 78.90%

Strategies used when ART unavailable in 2010

Page 13: Florin  Lazăr PhD, Lecturer Doru Buzducea  PhD, Assoc . prof

How was your life influenced by the interruptions? N Percentage

I felt worse 132 36.1%

I went to the hospital more often to take my medication 173 47.0% I spent more money commuting than I did for the medication 138 37.7%

I was forced to stop the treatment 226 61.5%

Consequences of interruptions

Page 14: Florin  Lazăr PhD, Lecturer Doru Buzducea  PhD, Assoc . prof

D3. When thinking about your ARV medication prescribed by the doctor Yes No DK/

NA

Does anybody remind you to take your medication? 34.8% 63.5% 1.7%

Does it happen for you to forget to take your medication? 41.1% 57.3% 1.6%

Does it happen for you not to care about the medication? 16.0% 82.0% 2.0%

Does it happen to stop taking the medication because you feel better? 6.2% 91.3% 2.3%

Does it happen not to take your medication because you feel worse after it? 7.5% 89.9% 2.6%

Did it happen to forget your ARV medication at least once during the last 4 days? 16.2% 81.6 % 2.1%

Did it happen for you to be some hours late from the prescribed time for the ARV medication? 42.2% 56.1% 1.7%

Some people forget to take their medication at the end of the week. Did it happen that you forget one last Saturday or Sunday?

11.7% 85.7% 2.6%

Adherence

100% self-declared adherence: 59.1% - last month/36.1% ever

Page 15: Florin  Lazăr PhD, Lecturer Doru Buzducea  PhD, Assoc . prof

Almost unlimited access

Little limited access

Limited access

Almost no access

Not the case/ Can’t tell

DK/ NA

ARV therapy 44.6% 42.4% 9.5% 1.3% 1.1% 1.2%

Treatment for opportunistic infections 21.0% 34.3% 20.2% 14.2% 7.8% 2.4%

Medical exams

a. Dentistry 10.5% 21.5% 24.7% 13.1% 27.6% 2.5%

b. Maternity 2.0% 5.4% 5.8% 3.5% 73.7% 9.6%

c. Gynaecology 4.3% 12.2% 11.2% 4.7% 59.4% 8.2%

d. Surgery 3.8% 9.0% 10.0% 8.8% 63.1% 5.1%

The possibility to discuss with other PLHIV 53.1% 29.6% 6.8% 4.3% 4.2% 2.0%

Joining a PLHIV association/ defending the rights of PLHIV 56.6% 23.9% 2.7% 2.6% 11.9% 2.3%

Job 9.9% 12.2% 13.1% 17.7% 44.3% 2.7%

Access to services

Page 16: Florin  Lazăr PhD, Lecturer Doru Buzducea  PhD, Assoc . prof

There were no more interruptions reported in 2011-2012 External factors (e.g. unintended treatment interruptions) +

internal factors (e.g. treatment fatigue) negatively affect adherence in long-term treated persons

Virologic monitoring to be improved Access to specialized medical services – limited More analysis on the adherence + support for maintaining Growing with HIV – treatment is part of everyday living Romanian authorities must ensure continuous treatment access

for PLHIV to prevent deterioration of the health status.

Conclusions

Page 17: Florin  Lazăr PhD, Lecturer Doru Buzducea  PhD, Assoc . prof

Research financed by:IrishAid Ireland and UNAIDS Regional Office through UNICEF Romania and

United Nations Development Programme.

Thank you!

Florin Lază[email protected]

Doru [email protected]